Home
>
National Drug Code (NDC)
>
Promolaxin
Promolaxin - 35356-822-60 - (Docusate sodium)
Drug Information of Promolaxin
| Product NDC: | 35356-822 |
| Proprietary Name: | Promolaxin |
| Non Proprietary Name: | Docusate sodium |
| Active Ingredient(s): | 100 mg/1 & nbsp; Docusate sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Promolaxin
| Product NDC: | 35356-822 |
| Labeler Name: | Lake Erie Medical DBA Quality Care Products LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part334 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110415 |
Package Information of Promolaxin
| Package NDC: | 35356-822-60 |
| Package Description: | 60 TABLET in 1 BOTTLE (35356-822-60) |
NDC Information of Promolaxin
| NDC Code | 35356-822-60 |
| Proprietary Name | Promolaxin |
| Package Description | 60 TABLET in 1 BOTTLE (35356-822-60) |
| Product NDC | 35356-822 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Docusate sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110415 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Lake Erie Medical DBA Quality Care Products LLC |
| Substance Name | DOCUSATE SODIUM |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
